[1] Mousa N, Abdel RA, Sheta T, et al. Serum leptin and homeostasis model assessment-IR as novel predictors of early liver fibrosis in chronic hepatitis B virus infection. Br J Biomed Sci, 2018, 75(4):192-196. [2] Ma H, Mak L, Cheung K, et al. Concomitant diabetes mellitus increases risk of liver fibrosis in treatment-naive chronic hepatitis B with low viral loads: results from a matched case-control study. J Hepatol, 2019, 70(1):264-268. [3] Sobhy A, Mohammed FM , Azeem HA , et al. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus. J Invest Med, 2019, 67(3):681-685. [4] Ladouceur M, Baron S, Antoine VN, et al. Role of myocardial collagen degradation and fibrosis in right ventricle dysfunction in transposition of the great arteries after atrial switch. Int J Cardiol, 2018, 258(7):83-89. [5] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年). 中华肝脏病杂志, 2019, 27(9):657-667. [6] Duman DG, Zibandeh N , Ugurlu MU , et al. Mesenchymal stem cells suppress hepatic fibrosis accompanied by expanded intrahepatic natural killer cells in rat fibrosis model. Mol Biol Rep, 2019, 46(3):2997-3008. [7] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2019年版).实用肝脏病杂志,2020,23(1)S9-32. [8] Melgar LP, Luquero A, Parra RM, et al. Graphene-dendrimer nanostars for targeted macrophage overexpression of metalloproteinase 9 and hepatic fibrosis precision therapy. Nano Lett, 2018, 18(9):5839-5845. [9] 闫瑞斌, 马淑梅, 卓玛, 等.慢性乙型肝炎患者血清MMP-2和TIMP-2水平及超声检查指标评估肝纤维化分期意义探讨. 实用肝脏病杂志, 2019, 22(4):506-510. [10] Lebda MA, Sadek KM,Abouzed TK , et al. Melatonin mitigates thioacetamide-induced hepatic fibrosis via antioxidant activity and modulation of proinflammatory cytokines and fibrogenic genes. Life Sci, 2018, 192(17):136-143. [11] Yue JY, Sun YY, Xu J, et al. Cucurbitane triterpenoids from the fruit of momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities. Phytochemistry, 2019, 157(2):21-27. [12] Kharat PB, More SD, Somvanshi SB, et al. Exploration of thermoacoustics behavior of water based nickel ferrite nanofluids by ultrasonic velocity method. J Mater Sci, 2019, 30(7):6564-6574. [13] Li DQ, Wei JX, Di BR, et al. Experimental study and theoretical interpretation of saturation effect on ultrasonic velocity in tight sandstones under different pressure conditions. Geophys J Int, 2017, 212(3):2226-2237. [14] 唐卫平, 胡琦, 戴小明, 等. 脂肪间充质干细胞移植对肝纤维化的治疗作用及其机制.中华肝脏病杂志, 2018, 26(1):28-33. [15] Keller S, Sedlacik J, Schuler T, et al. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis. Eur Radiol, 2018, 29(2):818-828. [16] Pozzi G, Albano D, Messina C, et al. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion eighted MRI using histology as a reference standard. J Magn ResonImaging, 2018,47(3):1034-0142. [17] Ge M, Liu H, Zhang Y, et al. The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. Br J Pharmacol, 2017, 174(10):1147-1160. [18] Li F, Yan HH, Wang JY, et al. Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrinαvβ3 expression with an MRI modality in mice. Biomaterials, 2016,102(9):162-174. [19] Soylu A, Kilickesmez O, Poturoglu S, et al. Utility of diffusion-weigh-ted MRI for assessing liver fibrosis inpatients with chronic active hepatits. Diagn Interv Radiol, 2010, 16(3):204-208. [20] Lee Y , Kim H . Assessment of diffusion tensor MR imaging (DTI) in liver fibrosis with minimal confounding effect of hepatic steatosis. Magn Reson Med, 2015, 73(4):1602-1608. [21] Taouli B, Chouli M, Martin AJ, et al. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging, 2008, 28(1):89-95. |